Home/Filings/4/0000950170-25-002497
4//SEC Filing

Galbraith Kenneth 4

Accession 0000950170-25-002497

CIK 0001937653other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 8:34 PM ET

Size

14.6 KB

Accession

0000950170-25-002497

Insider Transaction Report

Form 4
Period: 2025-01-06
Galbraith Kenneth
DirectorChair & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2025-01-06+66,666114,209 total
  • Sale

    Common Stock

    2025-01-06$14.92/sh33,406$498,55480,803 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-01-0647,66647,668 total
    Common Stock (47,666 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-01-0666,666133,334 total
    Common Stock (66,666 underlying)
  • Exercise/Conversion

    Common Stock

    2025-01-06+47,66671,428 total
  • Sale

    Common Stock

    2025-01-06$14.92/sh23,885$356,46247,543 total
Footnotes (7)
  • [F1]Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on January 5, 2023.
  • [F2]Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.44 to $15.14, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  • [F4]Represents shares of common stock issued upon vesting of one third of the RSUs granted on January 5, 2024.
  • [F5]Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
  • [F6]The RSUS were granted on January 5, 2023 and vest in three equal annual installments beginning on the first anniversary of January 5, 2023.
  • [F7]The RSUS were granted on January 5, 2024 and vest in three equal annual installments beginning on the first anniversary of January 5, 2024.

Documents

1 file

Issuer

Zymeworks Inc.

CIK 0001937653

Entity typeother

Related Parties

1
  • filerCIK 0001567045

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 8:34 PM ET
Size
14.6 KB